Susquehanna International Group, LLP Sangamo Therapeutics, Inc Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 1,809,550 shares of SGMO stock, worth $814,297. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,809,550
Previous 284,913
535.12%
Holding current value
$814,297
Previous $290,000
311.72%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding SGMO
# of Institutions
137Shares Held
51.2MCall Options Held
2.17MPut Options Held
1.82M-
Vanguard Group Inc Valley Forge, PA9.37MShares$4.22 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT6.87MShares$3.09 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.12 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.17MShares$1.43 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.28MShares$1.03 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $70.4M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...